Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 14/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 8/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.32 |
| ▸ | MYC | P01106 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23256520 | 0.99 | ABCG2 (0.34) | ABCG2ABCB1HTTABCC1MYC | |
| SCHEMBL23256825 | 0.97 | ABCG2 (0.35) | ABCG2ABCB1HTTABCC1MYC | |
| SCHEMBL23256643 | 0.97 | ABCG2 (0.35) | ABCG2ABCB1HTTABCC1MYC | |
| SCHEMBL23256761 | 0.96 | ABCG2 (0.34) | ABCG2ABCB1HTTABCC1OPRD1 | |
| SCHEMBL23257064 | 0.96 | ABCG2 (0.34) | ABCG2ABCB1HTTABCC1MYC | |
| SCHEMBL23257739 | 0.95 | ABCG2 (0.34) | ABCG2ABCB1HTTABCC1MYC | |
| SCHEMBL23257754 | 0.95 | ABCG2 (0.34) | ABCG2ABCB1HTTABCC1MYC | |
| SCHEMBL23257118 | 0.95 | ABCG2 (0.34) | ABCG2ABCB1HTTABCC1MYC | |
| SCHEMBL23257117 | 0.95 | ABCG2 (0.34) | ABCG2ABCB1HTTABCC1MYC | |
| SCHEMBL23256521 | 0.93 | ABCG2 (0.34) | ABCG2ABCB1HTTPDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210114998-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-04-22 | — | — | US | disclosed |
| WO-2019172699-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2019-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210114998-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CHRM1, CRY1, NR2E3 | ABCG2 4147/4885ABCB1 4430/4885HTT 2232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.